The National Cancer Institute is committed to dramatically lessening the impact of cancer.
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs are NCI’s engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer.
The SBIR & STTR Programs are one of the largest sources of early-stage technology
financing in the United States. We welcome entrepreneurs and small business leaders
to this website to explore grant and contract funding opportunities and a new spirit
of collaboration with the NCI.
[Learn More]
The NCI SBIR Development Center is interested in learning more about how SBIR & STTR funding is helping your company to achieve its cancer research goals and business objectives. Please click here to fill out a 'Share Your Story' form, and let us know about any developments with your NCI SBIR- or STTR-funded projects. Learn more about how other successful NCI SBIR & STTR companies are using their funding awards to advance cancer research.
Learn about Funding & Resources Available from the NCI SBIR & STTR Programs
Nature Biotechnology Publishes Article on the SBIR & STTR Programs
In an article published in Nature Biotechnology, SBIR & STTR Development Center staff discuss the application process and provide tips for applying for funding through the SBIR & STTR Programs.
Funding Opportunity: Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (SBIR-IMAT)
SBIR-IMAT supports research towards the commercial development of emerging molecular and/or cellular analytical technologies intended for cancer detection and/or characterization.
Receipt Date: May 28, 2014
The HHS SBIR & STTR 2013 Omnibus Solicitation is now expired. Keep checking back for information about the next opportunity.
NCI SBIR & STTR Grant Funding Available for:
- Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care
- Development of Highly Innovative Tools and Technology for Analysis of Single Cells
- Innovative Health IT for Broad Adoption by Healthcare Systems and Consumers
View a complete list of funding opportunities.
NCI Provocative Questions Initiative
NCI Director Harold Varmus launched a website as part of the Provocative Questions Initiative to identify the most important questions in the cancer research community.
